Binyamin, L., Alpaugh, R.K., Hughes, T.L., Lutz, C.T., Campbell, K.S., and Weiner, L.M. Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity (ADCC). J. Immunol. (in press).
MacFarlane IV, A.W., Yamazaki, T., Fang, M., Sigal, L.J., Kurosaki, T., and Campbell, K.S. Enhanced NK cell development and function in BCAP-deficient mice. Blood (in press).
Miah, S.S.M., Hughes, T.L., and Campbell, K.S. KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules. J. Immunol. 180: 2922-2932, 2008.
Hershkovitz, O., Jivov, S., Bloushtain, N., Zilka, A., Landau, G., Bar-Ilan, A., Glicklis, R., Campbell, K.S., van Kuppevelt, T.H., and Porgador, A. Characterization of the Recognition of Tumor and Virus-Infected Cells by the Natural Cytotoxicity Receptor, NKp44. Biochemistry, 46:7426-7436, 2007.
Chen, Y., Perussia, B., and Campbell, K.S. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. J. Immunol., 179:2766-2773, 2007.
Alvarez-Arias, D.A., and Campbell, K.S. Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells. J. Immunol. 179: 5281–5290, 2007.
MacFarlane IV, A.W., and Campbell, K.S. (2006) Signal transduction in natural killer cells. In Curr. Topics Microbiol. Immunol.: Immunobiology of natural killer cell receptors, Vivier, E. and Colonna, M., Eds., Springer, Heidelberg, Germany, 298:23-57.
Brando, C., Mukhopadhyay, S., Kovacs, E., Medina, R., Patel, P, Campbell, K.S., and Santoli, D. (2005) Receptors and lytic mediators regulating tumor cell lysis by the leukemic killer T cell line TALL-104. J. Leuk. Biol.,78:359-371.
Kikuchi-Maki, A., Catina, T.L., and Campbell, K.S. (2005) Cutting Edge: KIR2DL4 transduces signals into human NK cells through association with Fc receptor gamma protein. J. Immunol., 174:3859-3863.
Campbell, K.S., Yusa, S., Kikuchi-Maki, A., Catina, T.L. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. J. Immunol. 172:899-906, 2004.
Stoyanova, R.S., Clapper, M.L., Bellacosa, A., Henske, E.P., Testa, J.R., Ross, E.A., Yeung, A.T., Nicolas, E., Tsichlis, N., Li, Y.-S., Linehan, W.M., Howard, S., Campbell, K.S., Godwin, A.K., Boman, B., Crowell, J.A., Kopelovich, L., and Knudson, A.G. (2004) Altered gene expression patterns in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol. Ther., 3:1313-1321.
Yusa, S., Catina, T.L., Campbell, K.S. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). J. Immunol. 172:7385-7392, 2004.
Kikuchi-Maki, A., Yusa, S., Catina, T.L., Campbell, K.S. KIR2DL4 is an IL-2 regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN? production. J. Immunol. 171:3415-3425, 2003.
Kloeker, S., Reed, R., Popovich, J., Chang, D., Tran, K., Westphal, R.S., Law, B.K., Colbran, R.J., Kamoun, M., Campbell, K.S., Wadzinski, B.E. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase type 2A family (PP2Ac, PP4c, and PP6c) and analysis of the interaction of PP2Ac with alpha4 protein. Protein Expr. Purif. 31:19-33, 2003.
Yusa, S., Campbell, K.S. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. J. Immunol. 170:4539-4547, 2003.